Predicting breast cancer treatment outcome

Details for Australian Patent Application No. 2004274973 (hide)

Owner Arcturus Bioscience, Inc.

Inventors Erlander, Mark G.; Enright, Edward; Ma, Xiao-Jun; Sgroi, Dennis C.

Agent Pizzeys

Pub. Number AU-A-2004274973

PCT Pub. Number WO2005/028681

Priority 60/547,199 23.02.04 US; 10/727,100 02.12.03 US; 10/773,761 06.02.04 US; 60/504,087 19.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/028681 Priority application(s): WO2005/028681

17 July 2008 Alteration of Name

  The name of the applicant has been altered to AviaraDx, Inc.

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274977-Campylobacter polypeptides and methods of use

2004274957-Engineered zinc finger proteins for regulation of gene expression